Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 37538 | 55 | 11.3 | 43% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
| 346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
| 2496 | 2 | IFOSFAMIDE//CHEMOSENSITIVITY TEST//MESNA | 3914 |
| 37538 | 1 | HETEROCYCLIC TRIOXIRANES//TEROXIRONE//HUMAN NON SMALL CELL LUNG CANCER CELLS | 55 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | HETEROCYCLIC TRIOXIRANES | authKW | 555195 | 2% | 100% | 1 |
| 2 | TEROXIRONE | authKW | 555195 | 2% | 100% | 1 |
| 3 | HUMAN NON SMALL CELL LUNG CANCER CELLS | authKW | 46264 | 2% | 8% | 1 |
| 4 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | journal | 23903 | 16% | 0% | 9 |
| 5 | ONKOLOGIE | journal | 13730 | 15% | 0% | 8 |
| 6 | SPECIAL MAT | address | 11102 | 2% | 2% | 1 |
| 7 | CANCER TREATMENT REPORTS | journal | 9073 | 11% | 0% | 6 |
| 8 | ONKOL ZENTRUM | address | 8539 | 2% | 2% | 1 |
| 9 | CURRENT CONTENTS/CLINICAL PRACTICE | journal | 4370 | 2% | 1% | 1 |
| 10 | CANCER CLINICAL TRIALS | journal | 4335 | 2% | 1% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 904 | 65% | 0% | 36 |
| 2 | Pharmacology & Pharmacy | 108 | 27% | 0% | 15 |
| 3 | Chemistry, Medicinal | 45 | 9% | 0% | 5 |
| 4 | Chemistry, Multidisciplinary | 8 | 11% | 0% | 6 |
| 5 | Chemistry, Applied | 5 | 4% | 0% | 2 |
| 6 | Toxicology | 5 | 4% | 0% | 2 |
| 7 | Social Sciences, Interdisciplinary | 5 | 2% | 0% | 1 |
| 8 | Chemistry, Analytical | 5 | 5% | 0% | 3 |
| 9 | Engineering, Manufacturing | 4 | 2% | 0% | 1 |
| 10 | Thermodynamics | 1 | 2% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | SPECIAL MAT | 11102 | 2% | 2% | 1 |
| 2 | ONKOL ZENTRUM | 8539 | 2% | 2% | 1 |
| 3 | HUMAN DEV FAMILY STUDIES | 722 | 4% | 0% | 2 |
| 4 | KLINIKUM MANNHEIM | 653 | 2% | 0% | 1 |
| 5 | CHEM ANAL | 606 | 2% | 0% | 1 |
| 6 | MED KLIN 3 | 258 | 2% | 0% | 1 |
| 7 | ANAL | 212 | 2% | 0% | 1 |
| 8 | INAGE KU | 59 | 2% | 0% | 1 |
| 9 | CENT | 35 | 2% | 0% | 1 |
| 10 | CLIN MED | 13 | 2% | 0% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 23903 | 16% | 0% | 9 |
| 2 | ONKOLOGIE | 13730 | 15% | 0% | 8 |
| 3 | CANCER TREATMENT REPORTS | 9073 | 11% | 0% | 6 |
| 4 | CURRENT CONTENTS/CLINICAL PRACTICE | 4370 | 2% | 1% | 1 |
| 5 | CANCER CLINICAL TRIALS | 4335 | 2% | 1% | 1 |
| 6 | MANUFACTURING CHEMIST | 2999 | 2% | 1% | 1 |
| 7 | CANCER TREATMENT REVIEWS | 2571 | 5% | 0% | 3 |
| 8 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1891 | 9% | 0% | 5 |
| 9 | JOURNAL FUR PRAKTISCHE CHEMIE-PRACTICAL APPLICATIONS AND APPLIED CHEMISTRY | 1124 | 2% | 0% | 1 |
| 10 | CURRENT CONTENTS/LIFE SCIENCES | 901 | 2% | 0% | 1 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HETEROCYCLIC TRIOXIRANES | 555195 | 2% | 100% | 1 | Search HETEROCYCLIC+TRIOXIRANES | Search HETEROCYCLIC+TRIOXIRANES |
| 2 | TEROXIRONE | 555195 | 2% | 100% | 1 | Search TEROXIRONE | Search TEROXIRONE |
| 3 | HUMAN NON SMALL CELL LUNG CANCER CELLS | 46264 | 2% | 8% | 1 | Search HUMAN+NON+SMALL+CELL+LUNG+CANCER+CELLS | Search HUMAN+NON+SMALL+CELL+LUNG+CANCER+CELLS |
| 4 | CHEMOSENSITIVITY | 453 | 2% | 0% | 1 | Search CHEMOSENSITIVITY | Search CHEMOSENSITIVITY |
| 5 | OXALIPLATIN | 248 | 2% | 0% | 1 | Search OXALIPLATIN | Search OXALIPLATIN |
| 6 | CARBOPLATIN | 213 | 2% | 0% | 1 | Search CARBOPLATIN | Search CARBOPLATIN |
| 7 | CURCUMIN | 110 | 2% | 0% | 1 | Search CURCUMIN | Search CURCUMIN |
| 8 | CISPLATIN | 53 | 2% | 0% | 1 | Search CISPLATIN | Search CISPLATIN |
| 9 | P53 | 29 | 2% | 0% | 1 | Search P53 | Search P53 |
| 10 | APOPTOSIS | 4 | 2% | 0% | 1 | Search APOPTOSIS | Search APOPTOSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BEELEN, DW , SCHILCHER, RB , EHRLICH, R , QUABECK, K , SCHMIDT, U , SZY, D , GROSSEWILDE, H , BECHER, R , SCHAEFER, UW , (1991) HIGH-DOSE 1,2,4-TRIGLYCIDYLURAZOL GIVEN IN REGIMENS PREPARATORY TO BONE-MARROW TRANSPLANTATION - A PRECLINICAL PHARMACOLOGY STUDY.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 27. ISSUE 5. P. 361-366 | 9 | 90% | 0 |
| 2 | HEMPEL, A , CAMERMAN, N , CAMERMAN, A , (1989) CRYSTALLOGRAPHIC RESOLUTION AND CRYSTAL AND MOLECULAR-STRUCTURES OF STEREOISOMERS OF 1,3,5-TRIGLYCIDYL-S-TRIAZINETRIONE.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 32. ISSUE 3. P. 648-651 | 8 | 100% | 4 |
| 3 | TAKAISHI, K , MIYAMOTO, M , SEKI, T , MIYAMOTO, H , MORINO, A , SHIKII, K , HIDAKA, M , IKEDA, H , YAMAGUCHI, K , (1999) CRYSTAL STRUCTURES AND PHYSICAL PROPERTIES OF TRIS-(2,3-EPOXYPROPYL)ISOCYANATE.ANALYTICAL SCIENCES. VOL. 15. ISSUE 12. P. 1285-1286 | 5 | 100% | 2 |
| 4 | WANG, JP , LIN, KH , LIU, CY , YU, YC , WU, PT , CHIU, CC , SU, CL , CHEN, KM , FANG, K , (2013) TEROXIRONE INHIBITED GROWTH OF HUMAN NON-SMALL CELL LUNG CANCER CELLS BY ACTIVATING P53.TOXICOLOGY AND APPLIED PHARMACOLOGY. VOL. 273. ISSUE 1. P. 110-120 | 10 | 31% | 1 |
| 5 | QUEISSER, W , (2000) 30 YEARS OF MEDICAL ONCOLOGY.ONKOLOGIE. VOL. 23. ISSUE 4. P. 386-390 | 3 | 75% | 0 |
| 6 | HOLDENER, EE , CLAVEL, M , SESSA, C , HUININK, WT , SIEGENTHALER, P , LUDWIG, C , KLEPP, O , RENARD, G , DECOSTER, G , PINEDO, HM , (1994) PHASE-II TRIAL OF ANAXIRONE (TGU) IN ADVANCED COLORECTAL-CANCER - AN EORTC EARLY CLINICAL-TRIALS GROUP (ECTG) STUDY.EUROPEAN JOURNAL OF CANCER. VOL. 30A. ISSUE 3. P. 394-395 | 4 | 57% | 0 |
| 7 | FIEBIG, HH , HENSS, H , ARNOLD, H , VONBULTZINGSLOWEN, F , KLEE, M , QUEISSER, W , PEUKERT, M , (1987) PHASE-II TRIAL OF ANAXIRONE IN ADVANCED NON-SMALL CELL LUNG-CANCER.CANCER TREATMENT REPORTS. VOL. 71. ISSUE 5. P. 539-540 | 4 | 80% | 2 |
| 8 | NICAISE, C , ROZENCWEIG, M , CRESPEIGNE, N , DODION, P , GERARD, B , LAMBERT, M , KENIS, Y , DECOSTER, G , (1986) PHASE-I STUDY OF TRIGLYCIDYLURAZOL GIVEN ON A 5-DAY IV SCHEDULE.CANCER TREATMENT REPORTS. VOL. 70. ISSUE 5. P. 599-603 | 4 | 80% | 6 |
| 9 | CUNNINGHAM, D , SOUKOP, M , STUART, JFB , SETANOIANS, A , GILCHRIST, NL , FORREST, GJ , KAYE, SB , (1986) A CLINICAL AND PHARMACOKINETIC PHASE-I STUDY OF 1,2,4-TRIGLYCIDYLURAZOL (TGU, NSC 332488).EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. VOL. 22. ISSUE 11. P. 1325-1329 | 4 | 80% | 5 |
| 10 | RUBIN, J , KOVACH, JS , AMES, MM , MOERTEL, CG , CREAGAN, ET , OCONNELL, MJ , (1987) PHASE-I STUDY OF 2 SCHEDULES OF TEROXIRONE.CANCER TREATMENT REPORTS. VOL. 71. ISSUE 5. P. 489-492 | 3 | 100% | 3 |
Classes with closest relation at Level 1 |